货号:A341725
同义名:
甲吡酮
/ Su-4885; NSC 25265
Metyrapone is an inhibitor of cytochrome P450-mediated ω/ω-1 hydroxylase activity and CYP11B1.
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | Metyrapone is an inhibitor of cytochrome P450-mediated ω/ω-1 hydroxylase activity and CYP11B1. Administration of metyrapone to male rats induces the expression of the cytochrome P450 sub-family 3A (CYP3A)[3]. Metyrapone protects against ischemia- and excitotoxicity-induced brain damages in rodents[4]. Metyrapone is a glucocorticoid synthesis inhibitor largely used to study glucocorticoid involvement in stress and memory processes. Mice received first a saline injection and 2days later a 150mg/kg metyrapone injection. Metyrapone provoked immediately a waking effect together with a 3-h decrease in slow-wave sleep (SWS) and a 5-h decrease in rapid eye movement sleep (REM sleep)[5]. A significant rise in ACTH (adrenocorticotropin) concentration compared to basal values was found at 60 and 120 min following oral metyrapone administration[6]. Metyrapone was well tolerated and did not exacerbate cocaine's physiological effects[7]. Metyrapone (150 mg/kg) acutely reduced stress-induced physiological response in freely behaving rats independently from glucocorticoids and neurosteroids[8]. |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT00004334 | - | Unknown | - | United States, Michigan ... 展开 >> University of Michigan Health Systems Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Monica N. Starkman 313-764-6168 收起 << | |
NCT00310427 | Alcohol Dependence ... 展开 >> Alcoholism 收起 << | Phase 2 | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT00310427 | - | Completed | - | - | |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
4.42mL 0.88mL 0.44mL |
22.10mL 4.42mL 2.21mL |
44.19mL 8.84mL 4.42mL |
CAS号 | 54-36-4 |
分子式 | C14H14N2O |
分子量 | 226.27 |
SMILES Code | CC(C1=CC=CN=C1)(C)C(C2=CC=CN=C2)=O |
MDL No. | MFCD00006397 |
别名 | 甲吡酮 ;Su-4885; NSC 25265; Metyrapone, Metopirone, SU 4885, Methbipyranone, Methopyrapone |
运输 | 蓝冰 |
InChI Key | FJLBFSROUSIWMA-UHFFFAOYSA-N |
Pubchem ID | 4174 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Inert atmosphere, room temperature |